Emergency Medicine

Comprehensive Summary

Xu et al. conducted a multicenter, pragmatic randomized controlled trial comparing standard peripheral IV catheters (PIVCs) with long guidewire PIVCs (GW-PIVCs) in patients with difficult intravenous access (DIVA) presenting to emergency departments. The primary outcome was first-insertion success; prespecified secondary outcomes included device dwell time, device failure (all-cause), number of insertion attempts, patient and clinician satisfaction, and cost per participant. At two Australian EDs, adults meeting DIVA criteria were randomized to standard-of-care PIVCs (short or long, per usual practice) or to a 5.8-cm GW-PIVC with a retractable coiled guidewire. Ultrasound guidance was recommended in the GW-PIVC arm but discretionary in the standard-care arm: a design factor that may affect first-attempt success and requires explicit consideration in interpretation. Of 446 randomized participants (409 received a PIVC), first-attempt success was 68.0% with GW-PIVC versus 76.6% with standard PIVC (absolute difference 8.6%; OR 0.65; 95% CI 0.43–0.99; p<0.05). This corresponds to a number-needed-to-harm of approximately 12 (1 additional failed first attempt per ~12 patients) for GW-PIVC compared with standard PIVC. GW-PIVCs were more likely to be inserted by physicians or physicians-in-training (60.9% vs 39.0%), reflecting a shift in who performed the procedure. Separately, multiple insertion attempts occurred in 32.0% of GW-PIVC cases vs 22.5% of standard PIVCs (OR 1.62, 95% CI 1.06–2.48; p = 0.03). GW-PIVC was associated with a shorter median dwell time (8.3 h vs 16.2 h; mean difference −7.9 h; 95% CI −14.2 to −1.6; p=0.02), a clinically unfavorable finding. No statistically significant difference was observed in device failure or complication rates: 134.0 vs 111.8 per 1000 catheter-days; hazard ratio 1.18 (95% CI 0.72–1.95). Both patient and clinician satisfaction scores were lower in the GW-PIVC group: participant satisfaction 8/10 vs 9/10, median difference −1.00 (95% CI −1.37 to −0.63); clinician satisfaction 8/10 vs 10/10, median difference −2.00 (95% CI −2.37 to −1.63), indicating reduced acceptance of the device.

Outcomes and Implications

Although hypothesized to improve cannulation success, GW-PIVC showed trade-offs: a lower first-attempt success rate (absolute difference 8.6%; OR 0.65; 95% CI 0.43–0.99; p<0.05; NNH ≈ 12), shorter median dwell time, lower patient and clinician satisfaction, and substantially higher per-participant cost. These findings suggest that device rollout without structured operator training, standardized ultrasound protocols, and device familiarization may not improve (and could worsen) first-attempt success in DIVA patients. EDs considering GW-PIVC should pair introduction with proctored training, competency benchmarks for ultrasound-guided cannulation, and local pilot testing with prospective audit of first-attempt success and cost outcomes. Before broader adoption, implement a staged approach: a time-limited pilot (e.g., 3 months), formal training with competency assessment, and predefined success targets (e.g., first-attempt success within X% of baseline) before scaling up.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team